Mr. Philip Charlesworth

Mr. Philip Charlesworth
In 2007 Mr Philip Charlesworth initiated his Specialist Surgical training in Urology & Uro-Oncology within the hospitals of Berkshire, Buckinghamshire, Northamptonshire & Oxfordshire. The final years of specialist training were concentrated on robotic surgery, minimally invasive surgery & open surgery for major urological cancers and subsequent surgical reconstruction. In 2012, Mr Philip Charlesworth was awarded a British Urological Foundation Robotic Preceptorship with Professor Indebir Gill and his robotic surgical team at the University of Southern California Institute of Urology, Los Angeles, California, USA. Professor Inderbir Gill is arguably one of the greatest minimally invasive surgeons in the world. Mr Philip Charlesworth also has experience working with the robotic surgical teams of Guy’s & St Thomas Hospitals, London, Regina Elena Hospital, National Cancer Institute, Rome, Italy, and Harlev University Hospital, Copenhagen. Mr Philip Charlesworth was appointed as a substantive Consultant Surgeon at the Royal Berkshire Hospital in 2012 and joined the Reading Urology Partnership in 2013. Over this time, he has established himself as one of the leaders in pelvic uro-oncology (major prostate & bladder cancer) in the region. Mr Charlesworth has performed approximately 500 complex robotic major pelvic uro-oncological cancer operations in the past few years and is ranked as one of the highest volume surgeons according to nationally published statistics.

Locations

Berkshire Independent Hospital Coley Park, Reading,

Swallows Croft, Wensley RoadColey Park, Reading, RG1 6UZUnited Kingdom
0118 920 7040 | Visit Website

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only